Nanozyme-based biosensing for clinical diagnosis of COVID-19: A mini review

Saeed Reza Hormozi Jangi

2023-08-29

Abstract:Several clinical methods had been utilized for diagnosis of COVID-19 for instance, real-time reverse transcription-polymerase chain reaction (rRT-PCR), hematology examination, polymerase chain reaction (PCR), diagnostic guidelines based on clinical features, and Chest CT scans. However, the accurate current methods are time-consuming and expensive and other methods are inaccurate. To solve these drawbacks, nanozyme-based sensors have been developed for the reliable, accurate, and rapid detection of SARS-CoV-2. The main basis of these sensors is the detection of color variation of a nanozyme-mediated oxidation reaction in the presence and the absence of antigens of COVID-19. Besides, some of methods are based on probing the fluorescence of these systems as the clinical signal toward detection of SARS-CoV-2. This mini review focused on overviewing the nanozymes-based methods toward COVID-19 diagnosis. The historical background of COVID-19 was reviewed. Thereafter, the biomedical applications of nanozymes was discussed and finally, the recent progress of early diagnosis of COVID-19 based on nanozymatic systems was briefly reviewed.

Medical Physics,Quantitative Methods

What problem does this paper attempt to address?

The paper attempts to address some of the shortcomings in the current methods used for diagnosing COVID-19, such as real-time reverse transcription polymerase chain reaction (rRT-PCR), hematological examinations, polymerase chain reaction (PCR), clinical feature-based diagnostic guidelines, and chest CT scans, which are either time-consuming and expensive or not accurate enough. To solve these issues, researchers have developed nanozyme-based sensors to achieve reliable, accurate, and rapid detection of the SARS-CoV-2 virus. The main principle of these sensors is to detect the color change caused by the nanozyme-mediated oxidation reaction in the presence or absence of the SARS-CoV-2 antigen. Additionally, some methods are based on probing the fluorescence of these systems as a clinical signal to detect SARS-CoV-2. This mini-review focuses on outlining nanozyme-based methods for COVID-19 diagnosis, reviewing the historical background of COVID-19, and the biomedical applications of nanozymes, and finally, briefly reviewing the early diagnostic advances based on nanozyme systems.